30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Christina Rossi

Track

Insider profile

Currently holds a position at Blueprint Medicines Corp

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Commercial Officer Blueprint Medicines Corp Oct. 29, 2018 -
Christina Rossi's trades of Blueprint Medicines Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-08 2025-07-03
S Sale
26,562 -34.4%
468.71
US$2,736,704 		26,562 -34.4% 468.71 US$2,736,704
2025-05-21 2025-05-19
PlS Planned sale
51,833 -15.9%
114.57
US$2,303,530 		51,833 -15.9% 114.57 US$2,303,530
2025-05-21 2025-05-19
PlS Planned sale
33,672 +0.5%
423.19
US$4,554,437 		33,672 +0.5% 423.19 US$4,554,437
2025-05-21 2025-05-19
PlS Planned sale
804 -1.2%
100.14
US$80,513 		804 -1.2% 100.14 US$80,513
2025-05-07 2025-05-05
PlS Planned sale
144 -0.2%
103.56
US$14,913 		144 -0.2% 103.56 US$14,913
2025-05-07 2025-05-05
PlS Planned sale
180 -0.3%
102.82
US$18,508 		180 -0.3% 102.82 US$18,508
2025-05-07 2025-05-05
PlS Planned sale
1,343 -2.0%
101.77
US$136,677 		1,343 -2.0% 101.77 US$136,677
2025-05-07 2025-05-05
PlS Planned sale
607 -0.9%
100.97
US$61,289 		607 -0.9% 100.97 US$61,289
2025-03-26 2025-03-24
PlS Planned sale
2,274 -3.2%
95.02
US$216,075 		2,274 -3.2% 95.02 US$216,075
2025-03-24 2025-03-24
PrS Proposed sale
9,096
89.20
US$811,363 		9,096 89.20 US$811,363
2025-03-07 2025-03-05
S Sale
6,495 -8.3%
88.80
US$576,756 		6,495 -8.3% 88.80 US$576,756
2025-02-24 2025-02-20
PlS Planned sale
2,274 -3.4%
95.14
US$216,348 		2,274 -3.4% 95.14 US$216,348
2025-01-23 2025-01-21
PlS Planned sale
121 -0.2%
111.81
US$13,529 		121 -0.2% 111.81 US$13,529
2025-01-23 2025-01-21
PlS Planned sale
808 -1.2%
110.78
US$89,510 		808 -1.2% 110.78 US$89,510
2025-01-23 2025-01-21
PlS Planned sale
816 -1.2%
110.00
US$89,760 		816 -1.2% 110.00 US$89,760
2025-01-23 2025-01-21
PlS Planned sale
529 -0.8%
108.99
US$57,656 		529 -0.8% 108.99 US$57,656
2024-12-20 2024-12-18
PlS Planned sale
108 -0.2%
96.50
US$10,422 		108 -0.2% 96.50 US$10,422
2024-12-20 2024-12-18
PlS Planned sale
2,166 -3.0%
95.88
US$207,676 		2,166 -3.0% 95.88 US$207,676
2024-12-02 2024-11-27
PlS Planned sale
2,274 -3.1%
95.10
US$216,257 		2,274 -3.1% 95.10 US$216,257
2024-11-27 2024-11-27
PrS Proposed sale
9,096
94.63
US$860,754 		9,096 94.63 US$860,754
2024-03-11 2024-03-07
S Sale
6,070 -8.6%
90.69
US$550,488 		6,070 -8.6% 90.69 US$550,488
2023-03-08 2023-03-06
S Sale
99 -0.2%
44.28
US$4,384 		99 -0.2% 44.28 US$4,384
2023-03-08 2023-03-06
S Sale
2,960 -5.1%
45.72
US$135,331 		2,960 -5.1% 45.72 US$135,331
2022-11-07 2022-11-03
S Sale
533 -1.2%
45.24
US$24,113 		533 -1.2% 45.24 US$24,113
2022-03-08 2022-03-07
S Sale
1,047 -2.3%
56.19
US$58,831 		1,047 -2.3% 56.19 US$58,831
2022-03-08 2022-03-03
S Sale
1,197 -2.6%
60.28
US$72,155 		1,197 -2.6% 60.28 US$72,155
2022-03-23 2021-11-03
S Sale
511 -1.1%
110.85
US$56,644 		511 -1.1% 110.85 US$56,644
2021-03-05 2021-03-04
S Sale
1,272 -3.9%
86.61
US$110,168 		1,272 -3.9% 86.61 US$110,168
2021-03-05 2021-03-04
S Sale
87 -0.3%
89.10
US$7,752 		87 -0.3% 89.10 US$7,752
2020-11-05 2020-11-03
S Sale
345 -1.7%
99.69
US$34,393 		345 -1.7% 99.69 US$34,393
2020-03-11 2020-03-09
S Sale
135 -0.7%
51.96
US$7,015 		135 -0.7% 51.96 US$7,015